Follow-Up to Syneos Health Market Access for Weight Loss Drugs Podcast
Eli Lilly’s Zepbound has been approved by the FDA for the treatment of obesity, making it a competitor to Novo Nordisk’s extremely popular drug, Wegovy. What can pharmaceutical manufacturers do to ensure broader coverage of these antiobesity drugs?